Providers & Products

We have manufacturers, suppliers and service providers from the area PTCA catheter (Percutaneous Transluminal Coronary Angioplasty)

no results

Ihre Produkte genau hier!

Ihre Suche lieferte keine Ergebnisse, aber Sie können sich mit Ihren Produkten und Leistungen auf dieser Seite präsentieren

Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihre Produkte und Dienstleistungen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.

no results

Ihr Unternehmen genau hier!

Ihre Suche lieferte keine Ergebnisse, aber Sie können sich auf dieser Seite präsentieren

Mit einem Eintrag auf Weltzentrum der Medizintechnik platzieren Sie Ihr Unternehmen bei Google & Co. ganz weit oben und erreichen so jeden Tag mehrere Tausend potentielle Kunden aus der Medizintechnikbranche. Mehr Informationen gibt es auf der Firma eintragen - Seite.

PTCA catheter

PTCA catheter

The PTCA catheter is a balloon-tipped device used in the treatment of stenosis in coronary arteries. This procedure improves the perfusion of the heart and is useful for a variety of applications. It can also be used for acute myocardial infarction, in-stent restenosis, and post-deployment stent expansion. Listed below are the common indications for PTCA catheters.

PTCA catheters are often manufactured with materials that may cause adverse tissue reactions. These reactions can include localized cell death, rashes, edema, hemolysis, complement activation, thrombus formation, or even febrile episodes. In addition, the materials used to make a PTCA catheter can lead to device failure or excessive pressure on the patient's vessels. Consequently, patients must be informed of potential risks before undergoing PTCA catheter treatments.

A PTCA catheter must undergo a postmarket study before it can receive 510(k) clearance. This study is a requirement for a Class III device. The FDA defines the PTCA as a high risk device. As such, sponsors of clinical trials must have a valid IDE (Independent Device Evaluation) to conduct the study. They must comply with federal and state regulations regarding informed consent and institutional review boards.

The materials used in the manufacturing of a PTCA catheter may cause adverse tissue reactions in patients. These can include hemolysis, irritation, thrombus formation, and a variety of febrile reactions. During a PTCA procedure, patients may experience a balloon rupture. The balloon can break due to over-inflating it during the procedure or the tissue calcification of the shaft. Moreover, the shaft of a PTCA catheter may break due to improper bonding, excessive force, or a combination of these factors. In addition, adverse tissue reactions may result in the creation of an air embolism, stroke, aneurosm, and vascular rupture.

A PTCA catheter must be used in conjunction with accessory devices. Incompatible devices may lead to a failed PTCA procedure. A guidewire can be entangled during a PTCA procedure. This can lead to unstable angina and arrhythmias. Similarly, the improper sizing of a balloon can lead to a failed PTCA. As a result, the device should be reclassified.

During a PTCA procedure, a balloon is placed over the PTCA guidewire. This wire is then advanced over the stenosis. The balloon is continually inflated and deflated until the artery is patent. Then, the stent is placed in the stenosis area and cannot be removed after its expansion. This is a life-saving procedure for many patients, but the risks are high.

The PTCA catheter is a common medical device. However, the device is not without risk. The FDA recommends PTCA devices to be reclassified as class II. Special controls should be in place to prevent adverse outcomes. A PTCA device must be reclassified in order to prevent complications. It should be used before the expiration date of the package. A PTCA procedure is an important procedure that should be performed by a qualified physician.

In addition to the safety of patients, the FDA recommends that certain PTCA catheters should be reclassified to class II. The use of PTCA catheters should be regulated and controlled by the FDA. A PTCA system should not generate particulates or other harmful materials. The FDA has established special controls for PTCA devices. They will also monitor the device for safety and effectiveness in simulated use.

PTCA catheters operate by pressurizing an inflatable balloon at the distal end. It has a single or double lumen shaft. A balloon is located at the distal end and is designed to expand uniformly. The balloon has a defined burst pressure and a standardized rate of inflation. The PTCA catheter is not a surgical device and is a non-surgical treatment for coronary artery disease.

PTCA catheters are useful for a variety of applications. Depending on the location, a PTCA catheter can be used to treat a variety of conditions, such as stenosis. The PTCA balloon catheter has a specialized design and is used by doctors who have a high level of expertise in angioplasty. Using a PTCA balloon catheter can be a safer option than a stent.

Become a member of the “World Center for Medical Technology“

Become a digital exhibitor yourself in the online portal of the largest and best-known MedTech cluster region in Germany and inform the world of medical technology about your products and services as well as about news, events and career opportunities.

With an attractive online profile, we will help you to present yourself professionally on our portal as well as on Google and on social media.

Become a member
cd